Recruiting Follicular Lymphoma Studies in San Diego
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease...
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
The purpose of the study is to compare the efficacy of zanubrutinib plus obinutuzumab versus lenalidomide plus rituximab (R\^2) in participants with relapsed/refractory (R/R) follicular lymphoma (FL),...
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma....
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
This phase II trial studies how well obinutuzumab, ibrutinib, and venetoclax work in treating patients with previously untreated stage II-IV follicular lymphoma. Immunotherapy with obinutuzumab may in...
About Follicular Lymphoma Clinical Trials in San Diego
Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.
There are currently 5 follicular lymphoma clinical trials recruiting participants in San Diego, CALIFORNIA. These studies are seeking a combined 4,678 participants. Research is being sponsored by BioNTech SE, Genmab, BeiGene and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Follicular Lymphoma Clinical Trials in San Diego — FAQ
Are there follicular lymphoma clinical trials in San Diego?
Yes, there are 5 follicular lymphoma clinical trials currently recruiting in San Diego, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in San Diego?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Diego research site will contact you about next steps.
Are clinical trials in San Diego free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Diego studies also compensate for your time and travel.
What follicular lymphoma treatments are being tested?
The 5 active trials in San Diego are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov